Chronic kidney disease and congestive heart failure management: cardionephrologist's role

Authors

  • R. Rivera Clinica Nefrologica, Ospedale San Gerardo, Monza
  • F. Floccari U.O.C. Nefrologia e Dialisi, Ospedale San Paolo, Civitavecchia
  • L. Di Lullo U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro
  • A. Granata U.O.C. Nefrologia e Dialisi, Ospedale San Giovanni di Dio, Agrigento
  • F. Logias U.O.C. Nefrologia e Dialisi, Ospedale San Camillo, Sorgono
  • A. D’Amelio U.O.C. Nefrologia, Dialisi e Trapianto, Ospedale V. Fazzi, Lecce
  • F. Fiorini U.O.C. Nefrologia e Dialisi, Ospedale Santa Maria della Misericordia, Rovigo
  • V. Sala Clinica Nefrologica, Ospedale San Gerardo, Monza
  • A. Villani Scuola di Specializzazione in Nefrologia, Università degli Studi Tor Vergata, Roma
  • M. Malaguti U.O.C. Nefrologia e Dialisi, Ospedale San Paolo, Civitavecchia
  • A. Santoboni U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro
  • M. Timio Dipartimento di Nefrologia e Dialisi, Ospedale San Giovanni Battista, Foligno

DOI:

https://doi.org/10.33393/gcnd.2012.1123

Keywords:

Chronic heart failure (CHF), Chronic kidney disease (CKD), Diuretics, Ultrafiltration

Abstract

Kidney is mainly involved in fluid and electrolytes homeostasis, as well as in toxins knockout. Kidney function seems to be strictly related to heart and cardiovascular asset and ‘cardiorenal syndrome’ is now used to identify clinical correlation between heart and kidney disease. Chronic heart failure (CHF) represent first cause of hospitalization in western countries; CHF patients often present with mild to severe chronic kidney disease (CKD). Many physiological and pathophysiological pathways are postulated to explain how CKD can affect CHF prognosis and vice-versa. cGMP and NO - cGMP axis could be involved in pathogenesis of CHF in CKD patients together with natriuretic peptides (ANP and BNP) and phosphodiesterases control. Patients with CHF need to be treated for their chronic volume overload. First choice therapy is undoubtedly diuretic therapy, often with association between different kinds of drugs (such as thiazides and loop diuretics). Ultrafiltration excorporeal treatments are usually indicated in those patients not responding to massive diuretic treatments and they are often employed as complementary treatment in patients with refractory CHF.  (Cardionephrology)

Downloads

Download data is not yet available.

Published

2018-01-24

How to Cite

Rivera, R., Floccari, F., Di Lullo, L., Granata, A., Logias, F., D’Amelio, A., Fiorini, F., Sala, V., Villani, A., Malaguti, M., Santoboni, A., & Timio, M. (2018). Chronic kidney disease and congestive heart failure management: cardionephrologist’s role. Giornale Di Clinica Nefrologica E Dialisi, 24(1), 82–94. https://doi.org/10.33393/gcnd.2012.1123

Issue

Section

Cardionephrology

Metrics

Most read articles by the same author(s)

<< < 1 2 3 4 > >>